STOCK TITAN

PACS Group (PACS) accounting chief sells 15K shares in 10b5-1 trade

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

PACS Group, Inc. Chief Accounting Officer Michelle Renee Lewis sold 15,000 shares of common stock in an open-market transaction at a weighted average price of about $40.0119 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan, and she continues to hold 370,338 shares directly.

Positive

  • None.

Negative

  • None.

Insights

Planned insider sale of 15,000 PACS shares, with sizable holdings retained.

Chief Accounting Officer Michelle Renee Lewis sold 15,000 shares of PACS Group, Inc. common stock at a weighted average price of $40.0119 per share. The transaction is coded as an open-market sale of non-derivative common stock.

The filing notes the sale was effected under a pre-arranged Rule 10b5-1 trading plan adopted on March 3, 2026, indicating it was scheduled in advance rather than timed opportunistically. After the sale, she retains 370,338 shares directly, suggesting continued substantial equity exposure.

Because this appears to be a routine, pre-planned disposition with significant remaining holdings, it is best viewed as administrative portfolio management rather than a clear directional signal about the company’s prospects. Future company filings may provide additional context on ongoing 10b5-1 plan activity.

Insider Lewis Michelle Renee
Role Chief Accounting Officer
Sold 15,000 shs ($600K)
Type Security Shares Price Value
Sale Common Stock 15,000 $40.0119 $600K
Holdings After Transaction: Common Stock — 370,338 shares (Direct, null)
Footnotes (1)
  1. The sale reporting in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.00 to $40.085 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold 15,000 shares Open-market sale of common stock
Weighted average sale price $40.0119 per share Common stock sale on 2026-06-25
Post-transaction holdings 370,338 shares Shares directly held after sale
Sale price range $40.00–$40.085 per share Range of prices across multiple sale executions
Rule 10b5-1 trading plan regulatory
"The sale reporting in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
non-derivative financial
"transaction_type: non-derivative"
Form 4 regulatory
"The sale reporting in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lewis Michelle Renee

(Last)(First)(Middle)
C/O PACS GROUP, INC.
90 S. 400 W. SUITE 700

(Street)
SALT LAKE CITY UTAH 84101

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/25/2026S(1)15,000D$40.0119(2)370,338D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale reporting in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.
2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.00 to $40.085 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ John Mitchell, Attorney-in-Fact06/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PACS Group (PACS) report in this Form 4?

PACS Group reported that Chief Accounting Officer Michelle Renee Lewis sold 15,000 shares of common stock. The shares were sold as an open-market transaction at a weighted average price of about $40.0119 per share, according to the Form 4 disclosure.

Was the PACS Group (PACS) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sale was effected under a Rule 10b5-1 trading plan adopted by Michelle Renee Lewis on March 3, 2026. Such pre-arranged plans schedule trades in advance, reducing the significance of trade timing as an information signal.

How many PACS Group (PACS) shares does the insider hold after the sale?

After selling 15,000 shares, Chief Accounting Officer Michelle Renee Lewis directly holds 370,338 shares of PACS Group common stock. This remaining stake shows she continues to have substantial equity exposure to the company following the reported transaction.

What price range were the PACS Group (PACS) shares sold for in the Form 4?

The weighted average sale price reported is $40.0119 per share. The filing notes the shares were sold in multiple transactions at prices ranging from $40.00 to $40.085 per share, with full trade-by-trade detail available on request from specified parties.

What does the transaction code S mean in the PACS Group (PACS) Form 4?

Transaction code S indicates a sale in an open-market or private transaction. In this case, it identifies that Michelle Renee Lewis sold 15,000 shares of PACS Group common stock, rather than receiving them as compensation or exercising derivative securities.